ArticleNeurology2022

Humoral- and T-Cell-Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies.

Carla Tortorella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.